The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS):: Long-term follow-up of 100 patients

被引:55
|
作者
Roessle, M.
Siegerstetter, V.
Euringer, W.
Olschewski, M.
Kromeier, J.
Kurz, K.
Langer, M.
机构
[1] Univ Freiburg, Med Klin 2, Freiburg, Germany
[2] Univ Freiburg, Inst Diagnost Radiol, Freiburg, Germany
[3] Univ Freiburg, Dept Med Biometry, Freiburg, Germany
关键词
ascites; Budd-Chiari syndrome; stent graft; transjugular intrahepatic portosystemic shunt; transjugular shunt; variceal bleeding; Viatorr;
D O I
10.1080/02841850600806324
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To retrospectively evaluate results and clinical outcome of transjugular intrahepatic portosystemic shunt ( TIPS) after implantation of a polytetrafluoroethylene (PTFE)-covered stent graft. Material and Methods: The stent graft was used in 112 patients with higher risk of primary (i.e. patients with Budd-Chiari syndrome) or secondary shunt failure ( patients with occlusion of a previous uncovered stent), or a complicated TIPS procedure with an imminent technical complication requiring covered stent. Patients were scheduled at 3- to 6-month intervals for duplex-sonographic control of shunt function. Radiological revision was performed in patients with a decrease in shunt function by >25%, primary non-response, or relapse of the index symptom. Results: Twelve patients were lost to follow-up, and 100 patients were followed for 22 +/- 15 months. The actuarial rates of shunt patency were 90, 84, and 74% at 1, 2, and 3 years of follow-up, respectively. Two patients developed early ( within 1 month) and 14 patients late shunt failure. Except for one transient rise in liver enzymes due to outflow obstruction by the stent graft, no technical complications were seen. Primary response to treatment was seen in 97% of patients treated for variceal bleeding and 84% of patients treated for refractory ascites. A relapse of the index symptom was seen in 13% of bleeders and 9% of patients treated for refractory ascites. Conclusion: TIPS created with a PTFE-covered stent graft showed favorable long-term results.
引用
收藏
页码:660 / 666
页数:7
相关论文
共 50 条
  • [31] Transjugular Intrahepatic Portosystemic Shunt Through the Strut of a Previously Placed Stent: Technical Feasibility and Long-Term Follow-Up Results
    Munawwar Ahmed
    Shyamkumar Nidugala Keshava
    Vinu Moses
    George Koshy Chiramel
    Suraj Mammen
    C. E. Eapen
    Uday George Zachariah
    CardioVascular and Interventional Radiology, 2018, 41 : 1794 - 1798
  • [32] Transjugular Intrahepatic Portosystemic Shunt Through the Strut of a Previously Placed Stent: Technical Feasibility and Long-Term Follow-Up Results
    Ahmed, Munawwar
    Keshava, Shyamkumar Nidugala
    Moses, Vinu
    Chiramel, George Koshy
    Mammen, Suraj
    Eapen, C. E.
    Zachariah, Uday George
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (11) : 1794 - 1798
  • [33] Transjugular Intrahepatic Portosystemic Shunt Flow Reduction with Adjustable Polytetrafluoroethylene-covered Balloon-expandable Stents
    Kroma, Ghazwan
    Lopera, Jorge
    Cura, Marco
    Suri, Rajeev
    El-Merhi, Fadi
    Reading, Jerad
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2009, 20 (07) : 981 - 986
  • [34] Incidence, Natural History, and Risk Factors of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt With Polytetrafluoroethylene-Covered Stent Grafts
    Riggio, Oliviero
    Angeloni, Stefania
    Salvatori, Filippo Maria
    De Santis, Adriano
    Cerini, Federica
    Farcomeni, Alessio
    Attili, Adolfo Francesco
    Merli, Manuela
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (11): : 2738 - 2746
  • [35] Long-term outcome of covered and uncovered transjugular intrahepatic portosystemic shunt (TIPS) in Budd-Chiari syndrome
    Luong, Trinh K.
    Murad, Sarwa Darwish
    Pattynama, Peter M.
    Hansen, Bettina E.
    van Buuren, Henk R.
    Janssen, Harry L.
    HEPATOLOGY, 2006, 44 (04) : 457A - 458A
  • [36] LONG TERM FOLLOW UP OF PATIENTS TREATED WITH COATED STENTS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT
    Bandi, Juan C.
    Marciano, Sebastian
    Galdame, Omar A.
    Rostagno, Roman D.
    Garcia Monaco, Ricardo
    Gadano, Adrian
    HEPATOLOGY, 2010, 52 (04) : 1073A - 1073A
  • [37] Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures
    Otal, P
    Smayra, T
    Bureau, C
    Peron, JM
    Chabbert, V
    Chemla, P
    Joffre, F
    Vinel, JP
    Rousseau, H
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 178 (01) : 141 - 147
  • [38] Evaluation of impact of elective invasive examinations in patients with transjugular intrahepatic portosystemic shunt in the long-term follow up
    Seifert, Leon Louis
    Goerlich, Dennis
    Jansen, Christian
    Ortmann, Olessja
    Schoster, Martin
    Praktiknjo, Michael
    Gu, Wenyi
    Schindler, Philipp
    Koehler, Michael
    Maschmeier, Miriam
    Wilms, Christian
    Meyer, Carsten
    Schmidt, Hartmut H.
    Wildgruber, Moritz
    Trebicka, Jonel
    Heinzow, Hauke
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (01): : 24 - 34
  • [39] Persistence of gastric or esophageal varices on final angiography increases transjugular intrahepatic portosystemic shunt revision rate after polytetrafluoroethylene-covered stent shunt creation
    Moulin, Benjamin
    Chevallier, Olivier
    Abdulmalak, Gilles
    Luu, Maxime
    Latournerie, Marianne
    Minello, Anne
    Gehin, Sophie
    Cercueil, Jean-Pierre
    Midulla, Marco
    Loffroy, Romaric
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2018, 8 (02) : 174 - 181
  • [40] Long term follow up and pronostic factors after transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding.
    Magnin, F
    Perarnau, JM
    Pouli, IM
    GASTROENTEROLOGY, 1997, 112 (04) : A1326 - A1326